Drugs / MitoTempol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06466655 | May 2024 → Apr 2025 | major depressive disorder | University of Delaware | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MitoTempol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06466655 ↗ |
| Route | Other | “One intradermal microdialysis probes will be perfused with MitoTempol (0.5 mM)” NCT06466655 ↗ |